These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 20487847)

  • 1. Effect of Pro-Leu-Gly-NH(2) on plasma levels of ?-MSH in the rat.
    Celis ME; Thody AJ; Fisher C
    Neurochem Int; 1982; 4(1):27-31. PubMed ID: 20487847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the interaction between pro-leu-gly-NH2 and catecholaminergic drugs on MSH release from rat pituitaries incubated in vitro.
    Vivas A; Celis ME
    Neuroendocrinology; 1982; 35(3):150-4. PubMed ID: 6127639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. alpha-MSH and Pro-Leu-Gly-NH2 (PLG; MIF-1): influence on dopamine (DA) uptake in crude synaptosomal preparations from rat mediobasal hypothalamus (MBH) and caudate putamen (CP).
    Torre E; Celis ME; Chiocchio SR
    Peptides; 1984; 5(4):669-74. PubMed ID: 6149522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological activities of the MIF-1 analogues Pro-Leu-Gly, Tyr-Pro-Leu-Gly and pareptide.
    Mycroft FJ; Bhargava HN; Wei ET
    Peptides; 1987; 8(6):1051-5. PubMed ID: 2894644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a radioimmunoassay for Pro-Leu-Gly-NH2 (PLG or MIF-I): evidence that PLG is not present in rat brain.
    Manberg PJ; Youngblood WW; Kizer JS
    Brain Res; 1982 Jun; 241(2):279-84. PubMed ID: 6125241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New evidence that demonstrates that L-pro-L-leu-L-gly-NH2 might be the natural MIF.
    Vivas A; Celis ME
    Acta Physiol Lat Am; 1977; 27(4):177-82. PubMed ID: 31762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition by L-prolyl-L-leucyl-glycinamide (PLG) of alpha-melanocyte stimulating hormone release from hypothalamic slices.
    Scimonelli T; Celis ME
    Peptides; 1982; 3(6):885-9. PubMed ID: 6132363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of the blockade of alpha-melanocyte-stimulating hormone on LH release in the rat.
    Caballero C; Celis ME
    J Endocrinol; 1993 May; 137(2):197-202. PubMed ID: 8100849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. H-Pro-[3H]Leu-Gly-NH2: plasma profile and brain uptake following subcutaneous injection in the rat.
    Verhoef J; Prins A; Veldhuis HD; Witter A
    J Neurochem; 1982 Apr; 38(4):1135-8. PubMed ID: 6121002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significant differences in the degradation of pro-leu-gly-nH2 by human serum and that of other species (38484).
    Walter R; Neidle A; Marks N
    Proc Soc Exp Biol Med; 1975 Jan; 148(1):98-103. PubMed ID: 1168915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of melanotrophin release inhibiting factor (MIF) and cyclo (Leu-Gly) on the tolerance to morphine-induced antinociception in the rat: a dose-response study.
    Bhargava HN
    Br J Pharmacol; 1981 Apr; 72(4):707-14. PubMed ID: 6116510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure activity relationship studies with hypothalamic peptide hormones III. Effect of melanotropin-release inhibiting factor and analogs on tolerance to morphine in the rat.
    Bhargava HN; Kim HS
    Neuropharmacology; 1982 Sep; 21(9):917-22. PubMed ID: 6128692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of ACTH secretion by synthetic MSH-release inhibiting factor Pro-Leu-Gly-NH2 in Addison's disease.
    Voigt KH; Fehm HL; Lang RE; Beinert KE; Pfeiffer EF
    Horm Metab Res; 1977 Mar; 9(2):150-2. PubMed ID: 16818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure activity relationship studies with hypothalamic peptide hormones. I. Effect of melanotropin release inhibiting factor and analogs on tolerance to morphine in the rat.
    Bhargava HN; Kim HS
    J Pharmacol Exp Ther; 1982 Feb; 220(2):394-8. PubMed ID: 6120229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of melanotropin release inhibiting factor, its metabolites and analogs on [3H]spiroperidol and [3H]apomorphine binding sites.
    Bhargava HN
    Gen Pharmacol; 1983; 14(6):609-14. PubMed ID: 6141122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of Pro-Leu-Gly-NH2 analogues modified at the prolyl residue and evaluation of their effects on the receptor binding activity of the central dopamine receptor agonist, ADTN.
    Johnson RL; Rajakumar G; Yu KL; Mishra RK
    J Med Chem; 1986 Oct; 29(10):2104-7. PubMed ID: 2876104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of prolyl-leucyl-glycinamide and cyclo(leucyl-glycine) on the supersensitivity of dopamine receptors in brain induced by chronic administration of haloperidol to rats.
    Bhargava HN
    Neuropharmacology; 1984 Apr; 23(4):439-44. PubMed ID: 6145116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H-Pro-[3H]Leu-Gly-NH2: uptake and metabolism in rat brain.
    de Wildt D; Verhoef J; Witter A
    J Neurochem; 1982 Jan; 38(1):67-74. PubMed ID: 6125567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. H-Pro-[3H]Leu-Gly-NH2: metabolism in human and rat plasma investigated by high-pressure liquid chromatography.
    Witter A; Scholtens H; Verhoef J
    Neuroendocrinology; 1980 Jun; 30(6):377-81. PubMed ID: 6104307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Tyr-Pro-Leu-Gly-NH2 on melanotropin-stimulating hormone release in the frog and rat.
    Tonon MC; Leroux P; Saulot P; Vaudry H; Coy DH; Kastin AJ
    Gen Comp Endocrinol; 1983 Oct; 52(1):17-22. PubMed ID: 6138295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.